Tissue Technology LLC v. TAK Investments LLC

CourtCourt of Appeals for the Seventh Circuit
DecidedOctober 29, 2018
Docket18-1835
StatusPublished

This text of Tissue Technology LLC v. TAK Investments LLC (Tissue Technology LLC v. TAK Investments LLC) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Tissue Technology LLC v. TAK Investments LLC, (7th Cir. 2018).

Opinion

In the

United States Court of Appeals For the Seventh Circuit ____________________

No. 18-1835 TISSUE TECHNOLOGY, LLC, et al., Plaintiffs-Appellants,

v.

TAK INVESTMENTS, LLC, Defendant-Appellee. ____________________

Appeal from the United States District Court for the Eastern District of Wisconsin. No. 14-C-1203 — William C. Griesbach, Chief Judge. ____________________

ARGUED OCTOBER 22, 2018 — DECIDED OCTOBER 29, 2018 ____________________

Before FLAUM, EASTERBROOK, and SCUDDER, Circuit Judg- es. EASTERBROOK, Circuit Judge. In 2007 Tissue Technology and some affiliated entities, which the parties call the OFTI Group, sold a tissue mill in Oconto Falls, Wisconsin, to ST Paper, LLC, which is controlled by Tak Investments. Gold- man Sachs agreed to finance the transaction, but during the financial crunch of 2007 it cut $19 million from the amount of money it was willing to invest. That presented OFTI with 2 No. 18-1835

a problem: it had promised to give ST Paper clean title to the mill, but with the reduced financing it would be unable to pay off everyone who held a security interest. To help solve this problem, Tak Investments agreed to issue four negotia- ble notes, face values aggregating about $16 million, to OFTI, which would offer the notes to the creditors as substitute se- curity. The creditors accepted the notes, and the transaction closed. (Factual statements in this paragraph, and elsewhere in this opinion, come from findings the district court made after a bench trial. 320 F. Supp. 3d 993 (E.D. Wis. 2018).) The notes provided for 8% annual interest, with 10% of the principal payable at the end of the first year, another 10% at the end of the second, and the final 80% at the end of the third. In a side agreement, OFTI promised to pay the notes itself during the first three years (after which they should have been fully paid). This meant that the lenders who re- leased their security in the tissue mill had the credit of both Tak and OFTI behind the notes’ promises. The parties con- templated that Tak would hire a construction firm affiliated with OFTI to build at least $315 million worth of new tissue mills. The contracts provided that, if this occurred, Tak would not have to pay the notes. They also provided that, if Tak did not arrange for this construction (which the docu- ments called “Phase 2 Financing”), and Tak also did not pay the notes’ principal and interest, then OFTI could cancel the notes and acquire a 27% interest in Tak. That would be diffi- cult to accomplish as long as the lienholders held onto the notes as substitute collateral. But if OFTI paid off the debt secured by the notes and regained possession of these in- struments, and Tak refused to pay, OFTI could deem the notes cancelled and receive an equity interest. No. 18-1835 3

Tak never paid a penny on the notes it issued. Nor did OFTI comply with its obligation to pay during the first three years. The new tissue mills did not materialize. OFTI then demanded that Tak transfer to it an equity interest worth 27% of the company. When Tak refused, OFTI filed this suit under the diversity jurisdiction. As far as the district judge could determine, some of the formerly secured creditors have not been paid and retain at least three of the promisso- ry notes; but no maler who has the notes, the judge found, OFTI does not possess any of them. 320 F. Supp. 3d at 1003. At an early stage of this suit the district judge concluded that, because Tak does not own itself, it cannot be compelled to issue the 27% interest OFTI seeks. A corporation may be compelled to issue shares, the judge recognized, but only the existing members of a limited liability company may be compelled to transfer ownership interests. As Tak Invest- ments, LLC, is the sole defendant, the judge thought OFTI’s preferred remedy unavailable. 2016 U.S. Dist. LEXIS 166682 (E.D. Wis. Dec. 2, 2016). That was a misstep. Tak Investments is organized under Delaware law, to which the internal-affairs doctrine points as the source of rules about its powers. First National City Bank v. Banco Para el Comercio Exterior de Cuba, 462 U.S. 611, 621 (1983). Delaware permits a limited liability company to issue membership interests in itself, just as a corporation may is- sue shares, even if that dilutes the interests of existing mem- bers. 6 Del. Code §18-301(b)(1). The two existing members of Tak Investments do not assert any contractual or statutory right to prevent the issuance of new interests under §18- 301(b)(1), so Delaware law allows Tak to provide OFTI with an equity interest. But it became clear at trial that two other 4 No. 18-1835

considerations prevent OFTI from enforcing these notes against Tak. A hold-harmless agreement is the first of these reasons. Paragraph 2(I) of one agreement between OFTI and Tak pro- vides: Each member of the OFTI Group jointly and severally agrees to indemnify [Tak Investments] and to hold it harmless from and against any and all damages, losses, deficiencies, actions, de- mands, judgments, fines, fees, costs and expenses, including, without limitation, alorneys’ fees, of or against [Tak Invest- ments] resulting from enforcement of the Investment Notes by any member of the OFTI Group (other than the enforcement of the pledge described above), or any enforcement of or other claims made any [sic] other current or future holder of such In- vestment Notes against [Tak Investments] relating to the Invest- ment Notes.

The district court concluded that this effectively prevents OFTI from enforcing the notes against Tak, because whatev- er Tak gave to OFTI would be returned in indemnification. 320 F. Supp. 3d at 999–1002. That conclusion is inescapable. It makes business sense too. The notes were designed as security for third parties, not as compensation for OFTI. Per- haps, if OFTI paid the notes as it promised to do, it might be subrogated to the secured parties’ rights and could collect from Tak in that capacity notwithstanding the indemnity that blocks direct enforcement. But as OFTI did not pay the notes, it has no rights that it could enforce against Tak with- out immediately turning around and giving the money or other benefits (such as the 27% interest) back to Tak under the indemnity. (We could imagine an argument that obliga- tions arising from cancellation of the notes, as opposed to No. 18-1835 5

their enforcement, are not subject to the hold-harmless agreement. But OFTI does not make that argument.) The negotiability of the notes supplies the second reason. Each is payable to OFTI or another person it designates. Each was pledged to a lender to replace that lender’s securi- ty interest in the tissue mill, enabling OFTI to convey clear title to Tak. As far as the district judge could tell, none of the four notes has been returned to OFTI. This led the judge to invoke Wis. Stat. §403.301, a part of Wisconsin’s version of the Uniform Commercial Code applicable to negotiable in- struments, which provides: “Person entitled to enforce” an instrument means the holder of the instrument, a nonholder in possession of the instrument who has the rights of a holder, or a person not in possession of the in- strument who is entitled to enforce the instrument under s. 403.309 or 403.418(4). A person may be a person entitled to en- force the instrument even though the person is not the owner of the instrument or is in wrongful possession of the instrument.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Tissue Tech. LLC v. TAK Invs. LLC
320 F. Supp. 3d 993 (E.D. Wisconsin, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Tissue Technology LLC v. TAK Investments LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/tissue-technology-llc-v-tak-investments-llc-ca7-2018.